Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases

被引:36
|
作者
Kobayashi, Atsushi [1 ]
Kaido, Toshimi [1 ]
Hamaguchi, Yuhei [1 ]
Okumura, Shinya [1 ]
Shirai, Hisaya [1 ]
Kamo, Naoko [1 ]
Yagi, Shintaro [1 ]
Taura, Kojiro [1 ]
Okajima, Hideaki [1 ]
Uemoto, Shinji [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg,Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan
关键词
SKELETAL-MUSCLE; EICOSAPENTAENOIC ACID; HEPATIC RESECTION; PROGNOSTIC-FACTOR; TISSUE CONTENT; MASS INDEX; CANCER; SURVIVAL; HEPATECTOMY; MANAGEMENT;
D O I
10.1007/s00268-017-4255-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
We have reported preoperative low skeletal muscularity as an independent risk factor for poor outcomes after liver transplantation, resection of hepatocellular carcinoma, pancreatic cancer and extrahepatic biliary malignancies. However, the impacts of visceral adiposity and muscularity on outcomes after liver resection for colorectal liver metastases (CLM) have not been fully investigated. We retrospectively analyzed 124 patients undergoing primary liver resection for CLM between 2005 and 2014. Using preoperative computed tomography at the third lumbar vertebra level, skeletal muscle and abdominal adipose tissue were evaluated by skeletal muscle index (SMI), intramuscular adipose tissue content (IMAC) and visceral-to-subcutaneous adipose tissue area ratio (VSR), respectively. Impacts of preoperative SMI, IMAC and VSR on outcomes after liver resection for CLM were investigated. Low SMI and high VSR were not significantly associated with poor overall or recurrence-free survivals (P = 0.324 and P = 0.106, P = 0.964 and P = 0.738, respectively). Overall survival rate tended to be lower in patients with high IMAC than in patients with normal IMAC (P = 0.054). Recurrence-free survival rate did not differ significantly between high and normal IMAC (P = 0.721). Multivariate analysis showed that low SMI, high IMAC and high VSR were not significant risk factors for death or recurrence after liver resection for CLM. Neither preoperative visceral adiposity nor low muscularity were poor prognostic factors in patients undergoing liver resection for CLM.
引用
收藏
页码:1180 / 1191
页数:12
相关论文
共 50 条
  • [41] Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation
    Isiklar, Aysun
    Safer, Umut
    Safer, Vildan Binay
    Yiyit, Nurettin
    CLINICAL NUTRITION, 2019, 38 (02) : 964 - 965
  • [42] Surgical Outcomes of Hepatic Resection in Elderly Patients With Colorectal Liver Metastases
    Fatima, Javairiah
    Kavanagh, Crystal M.
    Nagorney, David M.
    Que, Florencia G.
    Harmsen, William S.
    Donohue, John H.
    Kendrick, Michael L.
    Farnell, Michael B.
    Lombardo, Kaye M. Reid
    GASTROENTEROLOGY, 2011, 140 (05) : S1018 - S1018
  • [43] A Non-Linear Association between Visceral Adiposity and Survival in Patients with Colorectal Liver Metastases
    Sogaolu, O.
    Coe, P. O.
    Parkin, E.
    Renehan, A. G.
    O'Reilly, D. A.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 26 - 26
  • [44] Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection
    Liu, Yueh-Wei
    Lu, Chien-Chang
    Chang, Ching-Di
    Lee, Ko-Chao
    Chen, Hong Hwa
    Yeh, Wen Shuo
    Hu, Wang-Hseng
    Tsai, Kai-Lung
    Yeh, Cheng-Hsi
    Wee, Sin-Yong
    Yin, Shin-Min
    Wang, Chih-Chi
    Hung, Chao-Hung
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [45] Peri-operative thrombophilia in patients undergoing liver resection for colorectal metastases
    Welsh, Fenella K. S.
    Walsh, Caoimhe M.
    Chandrakumaran, Kandiah
    Rathnaweera, Wasula S.
    Roy, Ashok
    Needham, Jane
    Cresswell, Adrian B.
    McVey, John H.
    Rees, Myrddin
    HPB, 2023, 25 (01) : 63 - 72
  • [46] Liver resection in patients with eight or more colorectal liver metastases
    Vigano, L.
    Capussotti, L.
    Majno, P.
    Toso, C.
    Ferrero, A.
    De Rosa, G.
    Rubbia-Brandt, L.
    Mentha, G.
    BRITISH JOURNAL OF SURGERY, 2015, 102 (01) : 92 - 101
  • [47] Preoperative CT and survival data for patients undergoing resection of colorectal liver metastases
    Amber L. Simpson
    Jacob Peoples
    John M. Creasy
    Gabor Fichtinger
    Natalie Gangai
    Krishna N. Keshavamurthy
    Andras Lasso
    Jinru Shia
    Michael I. D’Angelica
    Richard K. G. Do
    Scientific Data, 11
  • [48] The Validity of Clinical Risk Score for Patients Undergoing Liver Resection for Colorectal Metastases
    Ivanecz, Arpad
    Potrc, Stojan
    Horvat, Matjaz
    Jagric, Tomaz
    Gadzijev, Eldar
    HEPATO-GASTROENTEROLOGY, 2009, 56 (94-95) : 1452 - 1458
  • [49] Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases
    Loosen, Sven H.
    Roderburg, Christoph
    Alizai, Patrick H.
    Roeth, Anjali A.
    Schmitz, Sophia M.
    Vucur, Mihael
    Luedde, Mark
    Schoeler, David
    Paffenholz, Pia
    Tacke, Frank
    Trautwein, Christian
    Luedde, Tom
    Neumann, Ulf P.
    Ulmer, Tom F.
    DIAGNOSTICS, 2021, 11 (11)
  • [50] Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection
    Yueh-Wei Liu
    Chien-Chang Lu
    Ching-Di Chang
    Ko-Chao Lee
    Hong Hwa Chen
    Wen Shuo Yeh
    Wang-Hseng Hu
    Kai-Lung Tsai
    Cheng-Hsi Yeh
    Sin-Yong Wee
    Shin-Min Yin
    Chih-Chi Wang
    Chao-Hung Hung
    Scientific Reports, 10